The Allstate Corporation (ALL) financials
NYSE · Financial Services · Insurance - Property & Casualty · 53,150 employees · CEO Thomas Joseph Wilson
- Price
- $259.87 +1.54%
- Market cap
- $65.7B
- Enterprise value
- $72.4B
- Last report
- Q2 '26 filed 2026-08-05
- Next report
- 2026-11-04
Revenue (TTM)$69.2B+5.4% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)24.8%+13.7 pp vs a year agoOperating income $17.2B
Net income (TTM)$13.3B+128.6% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$12.2B+43.4% vs a year agoCapex $220M
Diluted EPS (TTM)$50.08+135.4% vs a year agoSum of the last 4 quarters
Net cash-$1.78B-169.9% vs a year agoCash + short-term investments - debt
Valuation & key figures
- Market cap
- $65.7B EV $72.4B
- Revenue
- $69.2B Trailing 12 months
- Revenue growth
- -8% FY2026 consensus
- Profit margin
- 19.2% Net income / revenue, TTM
- P/E
- 5.1× Forward 7.2× (FY2026)
- P/S
- 0.9× Price / sales, TTM
- EV / EBITDA
- 4.1× TTM
- Free cash flow
- $12.2B Trailing 12 months
- Net income
- $13.3B Trailing 12 months
- Revenue estimate
- $61B FY2026 consensus
- Earnings
- 2026-11-04
- Dividend
- $4.24 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Revenue growth accelerating: 12.4% year on yearQ2 '26 revenue $18.6B, against an average of 3.8% over the four quarters before.
- Operating margin 24.8% (TTM), +13.7 pp on a year agoOperating income grew 135.7% while revenue grew 5.4%.
- Capex 0.3% of revenue (a year ago 0.3%)$220M invested in the last 4 quarters (+7.8% on a year earlier). Free cash flow $12.2B = 92.0% of net income.
- Returned $3.53B to shareholders = 28.8% of free cash flowBuybacks $2.46B (a year earlier $441M), dividends $1.07B, stock-based pay $136M (TTM).
- Diluted share count down 3.3% in a year259M diluted shares in Q2 '26, 268M a year earlier.
- Net debt $1.78BCash + short-term investments $5.71B, debt incl. leases $7.49B; a year ago net cash $2.55B.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $18.6B | $16.5B | +12.4% |
| Gross margin | 34.7% | 24.4% | +10.4 pp |
| Operating income | $4.24B | $2.7B | +56.9% |
| Operating margin | 22.8% | 16.3% | +6.5 pp |
| Net income | $3.27B | $2.11B | +55.2% |
| Diluted EPS | $12.51 | $7.76 | +61.2% |
| Operating cash flow | $2.63B | $1.87B | +40.6% |
| Capex | $43M | -$1M | +4,400.0% |
| Free cash flow | $2.59B | $1.87B | +38.3% |
| R&D | $0 | $0 | – |
| Stock-based compensation | $0 | $0 | – |
Revenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q1 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Property Liability | – | – | – | – | – | |
| Protection Services | $915M | +7.6% | 100.0% | – | – | |
| Allstate Health And Benefits | – | – | – | – | – | |
| Intersegment Eliminations | – | – | – | – | – | |
| Corporate and Other | – | – | – | – | – |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $12.5B
- Capex
- -$220M
- Buybacks
- -$2.46B
- Dividends
- -$1.07B
- Acquisitions
- $0
- Net debt issued
- -$600M
- Stock-based compensation
- $136M
- Free cash flow
- $12.2B
- Returned to shareholders / FCF
- 28.8%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 5.1× | 13.3× 3 of 5 years | 5.4× – 23.3× |
| EV / EBITDA | 4.1× | 19.5× 4 of 5 years | 4.4× – 59.8× |
| EV / Sales | 1.0× | 0.9× | 0.8× – 0.9× |
| Price / FCF | 5.4× | 7.1× | 5.5× – 9.3× |
| Price / Book | 2.0× | 1.9× | 1.4× – 2.4× |
| FCF yield | 18.6% | 14.5% | 10.8% – 18.2% |
| Return on invested capital | 31.3% | 5.7% | -1.4% – 20.8% |
| Return on equity | 43.1% | 10.7% | -7.4% – 33.6% |
Analysts
Consensus target $266.31 (+2.5%)
range $221.00 – $319.00 · rating Hold
Strong buy1
Buy17
Hold24
Sell3
Strong sell0
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $61B | -8.3% | $35.93 | -5.9% | 7.2× | 14 |
| FY2027 | $62.1B | +1.9% | $28.05 | -21.9% | 9.3× | 13 |
| FY2028 | $64.1B | +3.1% | $26.61 | -5.2% | 9.8× | 4 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 338 figures The Allstate Corporation tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accrued Investment Income Receivable | $730M | $628M | +16.2% | $708M | $615M | +15.1% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $2.34B2025-12-31 | $2.5B | -6.4% | $2.34B | $2.5B | -6.4% |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax | -$10M | -$11M | +9.1% | -$11M | -$11M | 0.0% |
| Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax | -$126M | -$106M | -18.9% | -$55M | -$145M | +62.1% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$193M | -$57M | -238.6% | $255M | -$889M | +128.7% |
| Additional Paid in Capital, Common Stock | $4.22B | $4.08B | +3.3% | $4.16B | $4.03B | +3.2% |
| Additions to Contract Holders Funds | $0 | $0 | – | $30M | $129M | -76.7% |
| Amortization of Intangible Assets | $46M | $57M | -19.3% | $231M | $280M | -17.5% |
| Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries | $29.1B2025-12-31 | $25.5B | +14.0% | $29.1B | $25.5B | +14.0% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 700K | 500K | +40.0% | 400K | 500K | -20.0% |
| AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax | -$79M | $36M | -319.4% | $297M | -$771M | +138.5% |
| Assets | $125B | $116B | +7.6% | $120B | $112B | +7.3% |
| Assets Held by Insurance Regulators | $202M2025-12-31 | $194M | +4.1% | $202M | $194M | +4.1% |
| Assets, Fair Value Disclosure | $76.5B | $66.8B | +14.5% | $72B | $63.5B | +13.4% |
| Assumed Premiums Earned | – | – | – | $431M | $403M | +6.9% |
| Benefits, Losses and Expenses | $14.5B | $14.8B | -2.5% | $56.1B | $58.3B | -3.8% |
| Business Combination, Contingent Consideration, Liability | $28M2025-12-31 | $25M | +12.0% | $28M | $25M | +12.0% |
| Capitalized Computer Software, Net | $349M2025-12-31 | $398M | -12.3% | $349M | $398M | -12.3% |
| Cash | $840M | $995M | -15.6% | $678M | $704M | -3.7% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $840M | $995M | -15.6% | $678M | $704M | -3.7% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $143M | $45M | +217.8% | -$26M | -$18M | -44.4% |
| Ceded Premiums Earned | – | – | – | $2.68B | $2.26B | +18.6% |
| Collateral Already Posted, Aggregate Fair Value | $1M | $36M | -97.2% | $14M | $0 | – |
| Common Stock, Dividends, Per Share, Declared | $1.08 | $1.00 | +8.0% | $4.00 | $3.68 | +8.7% |
| Common Stock, Par or Stated Value Per Share | $0.01 | $0.01 | 0.0% | $0.01 | $0.01 | 0.0% |
| Common Stock, Shares Authorized | 2B | 2B | 0.0% | 2B | 2B | 0.0% |
| Common Stock, Shares, Issued | 900M | 900M | 0.0% | 900M | 900M | 0.0% |
| Common Stock, Shares, Outstanding | 254M | 264M | -3.8% | 260M | 265M | -1.9% |
| Common Stock, Value, Outstanding | $9M | $9M | 0.0% | $9M | $9M | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | $0 | -$11M | +100.0% | -$13M | -$58M | +77.6% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $3.37B | $2.56B | +31.5% | $11.4B | $4.47B | +155.7% |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | $3.37B | $2.55B | +32.1% | $11.4B | $4.41B | +158.7% |
| Current Federal Tax Expense (Benefit) | – | – | – | $2.51B | – | – |
| Current Foreign Tax Expense (Benefit) | – | – | – | $99M | – | – |
| Current Income Tax Expense (Benefit) | – | – | – | $2.73B | $1.18B | +131.9% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $122M | – | – |
| Debt Issuance Costs, Net | $51M2025-12-31 | $56M | -8.9% | $51M | $56M | -8.9% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | $445M | $633M | -29.7% | $777M | $361M | +115.2% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $538M | $581M | -7.4% | $392M | $1.23B | -68.1% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Amortized Cost | $12.9B | $6.41B | +100.9% | $9.71B | $10.5B | -7.7% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Fair Value | $12.9B | $6.26B | +105.5% | $9.69B | $10.3B | -5.5% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost | $21.1B | $13.1B | +61.7% | $21.5B | $17.4B | +23.6% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value | $21.1B | $13.2B | +60.2% | $21.8B | $17.1B | +27.1% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost | $21.2B | $31.2B | -32.0% | $22.6B | $22.9B | -1.3% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value | $21.2B | $31.3B | -32.4% | $22.7B | $22.6B | +0.5% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost | $1.6B | $1.64B | -2.4% | $1.46B | $1.54B | -5.2% |
| Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value | $1.6B | $1.63B | -1.7% | $1.46B | $1.53B | -4.6% |
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost | $4.1B | $2.06B | +99.2% | $3.43B | $1.23B | +180.1% |
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | $4.09B | $2.08B | +96.4% | $3.48B | $1.24B | +180.3% |
| Debt Securities, Gain (Loss) | -$80M | -$245M | +67.3% | -$253M | -$160M | -58.1% |
| Debt, Long-term and Short-term, Combined Amount | $7.49B2025-12-31 | $8.09B | -7.4% | $7.49B | $8.09B | -7.4% |
| DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | $10M | $17M | -41.2% | $10M | $17M | -41.2% |
| DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | $60.9B | $54.4B | +12.0% | $58.7B | $53.6B | +9.5% |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterest | $60.8B | $54.4B | +11.7% | $59.1B | $52.7B | +12.1% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $103M | – | – |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $7M | – | – |
| Deferred Income Tax Assets, Net | $12M2026-03-31 | $229M | -94.8% | $0 | $231M | -100.0% |
| Deferred Income Tax Expense (Benefit) | – | – | – | $156M | -$17M | +1,017.6% |
| Deferred Income Tax Liabilities, Net | $172M | – | – | $227M | $0 | – |
| Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Addition | – | – | – | $8.78B | $8.39B | +4.7% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-01